The "gradual decline" group (approximately 40-50% of users) represents modal experience where benefits slowly regress toward pre-treatment baseline over 4-8 months, typically affecting users who completed shorter treatment courses (2-4 months), used lower concentrations or inconsistent application, possessed moderate to severe baseline skin damage requiring ongoing support, maintained adequate but not optimal complementary skincare, experienced significant lifestyle stressors affecting skin health including poor sleep or high stress, and faced genetic or age-related collagen production limitations
Regarding SOD activity (Fig
Fletcher MM, Belousoff MJ, Harikumar KG, et al
Figure 7 (A) The dimeric GSAAT1 structure shows the positions of conserved Cys residues at positions 138 (98 in the model), 168 (128 in the model), 190(150 in the model), and 396 (356 in the model), each marked by red circles
That is the clinical rationale behind the Wolverine protocol, which we cover in full detail in our dedicated guide to the Wolverine peptide stack at Perfect B, explaining the BPC-157 plus TB-500 combination protocol for comprehensive recovery